Allevian
Natural health product licensed in Canada
- Licence holder
- UHTCO Corporation
- NPN or DIN-HM
- 80055914
- Status
- Active licence
- Licence date
- 25 November 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lepidium meyenii Source : Lepidium meyenii - racine Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 3,360 mg | 420 mg | Not calculated |
| Uncaria tomentosa Source : Écorce âgée Extract : Matériel brut sec Extraction ratio : 12:1 Dry plant equivalent : 2,160 mg | 180 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
U. tomentosa is used in Herbal Medicine to help relieve symptoms associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if pregnant or breastfeeding. Do not use if you suffer from an immune system disorder (e.g. Crohn's disease, myasthenia gravis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, HIV/AIDs etc), cancer, asthma, are taking immunosuppressants, are awaiting organ transplant, or have severe allergies.
- Effets indésirables connus
Diarrhea and indigestion have been known to occur. Discontinue use if you experience digestive upset.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking prescription medication, antidepressants or blood thinners. Consult a health care practitioner prior to use if you have a liver disorder or high blood pressure. Consult a health care practitioner prior to use if you are taking anticoagulant or antihypertensive medication.
Source
Official Health Canada record, licence 80055914
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.